U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C53H87NO19.C4H6O6
Molecular Weight 1192.34
Optical Activity UNSPECIFIED
Defined Stereocenters 23 / 23
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TYLVALOSIN TARTRATE

SMILES

O[C@H]([C@@H](O)C(O)=O)C(O)=O.[H][C@@]1(C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O1)O[C@@H]2[C@@H](C)O[C@@]([H])(O[C@H]3[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@H](CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)[C@@H](CC)OC(=O)C[C@@H](OC(C)=O)[C@@H]3C)[C@H](O)[C@H]2N(C)C

InChI

InChIKey=OLLSDNUHBJHKJS-XKORHJEPSA-N
InChI=1S/C53H87NO19.C4H6O6/c1-16-38-36(26-65-52-49(64-15)48(63-14)44(60)31(7)67-52)22-28(4)17-18-37(57)29(5)23-35(19-20-55)46(30(6)39(69-34(10)56)24-41(59)70-38)73-51-45(61)43(54(12)13)47(32(8)68-51)72-42-25-53(11,62)50(33(9)66-42)71-40(58)21-27(2)3;5-1(3(7)8)2(6)4(9)10/h17-18,20,22,27,29-33,35-36,38-39,42-52,60-62H,16,19,21,23-26H2,1-15H3;1-2,5-6H,(H,7,8)(H,9,10)/b18-17+,28-22+;/t29-,30+,31-,32-,33+,35+,36-,38-,39-,42+,43-,44-,45-,46-,47-,48-,49-,50+,51+,52-,53-;1-,2-/m11/s1

HIDE SMILES / InChI

Molecular Formula C4H6O6
Molecular Weight 150.0868
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula C53H87NO19
Molecular Weight 1042.2532
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 21 / 21
E/Z Centers 0
Optical Activity UNSPECIFIED

Tylvalosin tartrate is a third-generation macrolide antibiotic that has antibacterial activity against Gram-positive, some Gram-negative organisms and mycoplasma. Tylvalosin interferes with protein synthesis by reversibly binding to the 50S ribosome subunit. Tylvalosin binds to the donor site and prevents the translocation necessary for keeping the peptide chain growing. Its effect is essentially confined to rapidly dividing organisms. Tylvalosin tartrate is the active ingredient of Aivlosin -- a modern macrolide that has shown its effectiveness in the control of porcine proliferative enteropathy, EP and swine dysentery.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
AIVLOSIN

Approved Use

Control of porcine proliferative enteropathy (PPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPE.

Launch Date

1.3415328E12
PubMed

PubMed

TitleDatePubMed
In vitro activity of tylvalosin against Spanish field strains of Mycoplasma hyopneumoniae.
2014 Nov 29
Use of tylvalosin in the control of porcine enzootic pneumonia.
2015
Antibiotic susceptibility profiles of Mycoplasma sp. 1220 strains isolated from geese in Hungary.
2016 Aug 19
Antimicrobial susceptibility of Brachyspira hyodysenteriae in Switzerland.
2016 Jun
Patents

Patents

Sample Use Guides

Control of porcine proliferative enteropathy: 50 ppm tylvalosin in drinking water for five consecutive days
Route of Administration: Oral
Tylvalosin (MIC50 0.5 ug/ml) was found to be the most effective drug against M. sp. 1220.
Substance Class Chemical
Created
by admin
on Wed Jul 05 23:54:40 UTC 2023
Edited
by admin
on Wed Jul 05 23:54:40 UTC 2023
Record UNII
AL5667FY0W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TYLVALOSIN TARTRATE
USAN  
USAN  
Official Name English
TYLVALOSIN TARTRATE [GREEN BOOK]
Common Name English
ACETYLISOVALERYLTYLOSIN TARTRATE
Common Name English
ACETYLISOVALERYLTYLOSIN TARTRATE [JAN]
Common Name English
TYLVALOSIN TARTRATE [MI]
Common Name English
TYLVALOSIN TARTRATE [USAN]
Common Name English
AIVLOSIN
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C254
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
Code System Code Type Description
FDA UNII
AL5667FY0W
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
PUBCHEM
56840638
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
ChEMBL
CHEMBL2103834
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
NCI_THESAURUS
C152788
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
SMS_ID
300000023613
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
MERCK INDEX
M11759
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
RXCUI
1368468
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY RxNorm
USAN
UU-50
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
CAS
63428-13-7
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
DRUG BANK
DBSALT001708
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
DAILYMED
AL5667FY0W
Created by admin on Wed Jul 05 23:54:40 UTC 2023 , Edited by admin on Wed Jul 05 23:54:40 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE